EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management—Reanalysis of Retrospective Bacteremia Cohorts

Helena Lindberg, Andreas Berge, Martin Jovanovic-Stjernqvist, Malin Hagstrand Aldman, David Krus, Jonas Öberg, Fredrik Kahn, Anna Bläckberg, Torgny Sunnerhagen, Magnus Rasmussen iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Helena Lindberg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital of Halland, Halmstad, Sweden. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis, Bacteremia, Communicable Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Halland Research Council, Foundation of Sparbanken Varberg, Swedish Government Funds for Clinical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Revised diagnostic criteria for infective endocarditis (IE), the 2023 Duke-ISCVID criteria, were recently presented and need validation. Here, we compare the 2000 modified Duke criteria for IE with Duke-ISCVID among patients with bacteremia and relate the diagnostic classification to IE treatment.

Methods

We reanalyzed patient cohorts with Staphylococcus aureus, Staphylococcus lugdunensis, non–β-hemolytic streptococci, Streptococcus-like bacteria, Streptococcus dysgalactiae, Enterococcus faecalis, and HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella) bacteremia. Episodes were classified as definite, possible, or rejected IE with the modified Duke and Duke-ISCVID criteria. Reclassification included the microbiology criteria, positron emission tomography–computed tomography, and cardiac implanted electronic devices. To calculate sensitivity, patients treated for IE were considered as having IE.

Results

In 4050 episodes of bacteremia, the modified Duke criteria assigned 307 episodes (7.6%) as definite IE, 1190 (29%) as possible IE, and 2553 (63%) as rejected IE. Using the Duke-ISCVID criteria, 13 episodes (0.3%) were reclassified from possible to definite IE, and 475 episodes (12%) were reclassified from rejected to possible IE. With the modified Duke criteria, 79 episodes that were treated as IE were classified as possible IE, and 11 of these episodes were reclassified to definite IE with Duke-ISCVID. Applying the decision to treat for IE as a reference standard, the sensitivity of the Duke-ISCVID criteria was 80%. None of the 475 episodes reclassified to possible IE were treated as IE.

Conclusions

The Duke-ISCVID criteria reclassified a small proportion of episodes to definite IE at the expense of more episodes of possible IE. Future criteria should minimize the possible IE group while keeping or improving sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endocarditis, BacterialEndocarditisBacteremiaCommunicable DiseasesHumansRetrospective Studies

Stichwörter der Autor:innen

bacteremiadiagnostic criteriainfective endocarditisvalidation

Autor:innen und Institutionen

  • Department of Infectious Diseases, Hospital of Halland, Halmstad, Sweden.
  • Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital Stockholm, Sweden.
  • Department of Infectious Diseases, Skåne University Hospital Lund, Sweden.
  • Department of Infectious Diseases, Helsingborg Hospital, Helsingborg, Sweden.

ORCID-Profile: Magnus Rasmussen

Förderung

  • Region Halland Research Council
  • Foundation of Sparbanken Varberg
  • Swedish Government Funds for Clinical Research
  • Skåne University Hospital

Zitieren

APA

Lindberg, H., Berge, A., Jovanovic-Stjernqvist, M., Hagstrand Aldman, M., Krus, D., Öberg, J., Kahn, F., Bläckberg, A., Sunnerhagen, T., & Rasmussen, M. (2024). Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management—Reanalysis of Retrospective Bacteremia Cohorts. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae040

Vancouver

Lindberg H, Berge A, Jovanovic-Stjernqvist M, Hagstrand Aldman M, Krus D, Öberg J, et al. Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management—Reanalysis of Retrospective Bacteremia Cohorts. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae040

BibTeX
@article{Lindberg2024,
  author = {Lindberg, Helena and Berge, Andreas and Jovanovic-Stjernqvist, Martin and Hagstrand Aldman, Malin and Krus, David and Öberg, Jonas and Kahn, Fredrik and Bläckberg, Anna and Sunnerhagen, Torgny and Rasmussen, Magnus},
  title = {Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management—Reanalysis of Retrospective Bacteremia Cohorts},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae040}
}
Kostenlos starten →